USDA, Western Human Nutrition Research Center
Trial Pipeline
Metabolic and Bio-behavioral Effects of Following Recommendations in the Dietary Guidelines for Americans
NCT04293224
WHNRC (Western Human Nutrition Research Center) Honey Study
NCT06107231
Induction of Gut Permeability by an Oral Vaccine
NCT04083950
Assessing Diet, Stress Scores, and Other Health Metrics in Healthy Northern California Adults
NCT07265648
Yogurt and GI Health
NCT05931471
Investigating the Stability, Variability and Mechanism of Incorporation of Lipid Mediators Into Eccrine Sweat
NCT02935894
Beta-carotene Absorption and Bioconversion to Vitamin A From Biofortified Cassava Gari
NCT02210507
Effect of Intense Training on Ovarian Function and Bone Turnover
NCT02224976
The Effects of Antioxidants in Blueberry Powder on Inflammation Induced by a Single High Fat Meal.
NCT01594008
Identification of Muscle-specific Biomarkers of Fatty Acid Beta-oxidation
NCT01494025
Low Energy Availability, Menstrual Irregularity, and Low Bone Mass
NCT01059968
Metabolism And Health Effects Of Citrus Limonoids in Hypercholesterolemic Humans
NCT02011789
Dairy Foods and Weight Loss
NCT00858312
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
What the Pipeline for USDA, Western Human Nutrition Research Center Shows
According to the ClinicalTrials.gov registry, USDA, Western Human Nutrition Research Center is linked to 13 US clinical trials across every stage of research activity. Of those, 1 studies are currently recruiting — about 8% of the sponsor's indexed portfolio — and 10 are already marked complete, representing roughly 77% of the total. Recruiting share is one of the more practical signals here: it reflects how much of a sponsor's research is presently open to new participants, while the completed share indicates the depth of finished work that has already contributed registry results. Both counts come directly from the public ClinicalTrials.gov dataset and are refreshed on the registry side; this page mirrors the latest data pull without altering it.
The phase mix for USDA, Western Human Nutrition Research Center reports 0 late-stage studies (Phase 3 and Phase 4 combined) and 1 earlier-phase studies (Phase 1 and Phase 2). A portfolio weighted toward Phase 3 usually reflects an organization advancing candidates toward regulatory review, where the research centers on comparative efficacy and broader safety across larger populations. A heavier Phase 1 and Phase 2 tilt generally indicates exploratory work — safety, dosing, and early signal detection — and is common among research-forward sponsors that seed many early programs. Phase 4 entries, when present, track interventions already in real-world use and typically focus on long-term safety, effectiveness across subgroups, or formulation comparisons.
The top therapeutic focus area indexed for USDA, Western Human Nutrition Research Center is Inflammation with 2 linked trials, and 9 other condition areas appear in the top list above. That distribution is a quick read of where the organization concentrates its research attention; it does not imply product availability, market share, or any clinical endorsement. All numbers on this page come from ClinicalTrials.gov maintained by the National Library of Medicine, and counts can shift as new studies are registered or existing ones update their status. This information is provided for reference and educational purposes only, not as medical, investment, or regulatory advice — verify current details directly with ClinicalTrials.gov before relying on any figure here.
Read our methodology — how this data is sourced, computed, and verified.